Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended				6 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2019	Sep. 30, 2019	Dec. 31, 2019
Cash flows from operating activities:
Net (loss) income attributable to Flotek Industries, Inc. (Flotek)	$ (63,967)			$ 30,862
Less: Income from discontinued operations, net of tax	0	$ (2,425)	$ (1,608)	46,074	$ 44,466	$ 44,583	$ 42,158
Loss from continuing operations	(63,967)			(15,212)
Adjustments to reconcile loss from continuing operations to net cash used in operating activities:
Depreciation and amortization	2,191			2,260
Amortization of deferred financing costs	0			1,428
Provision for doubtful accounts	597			366
Provision for excess and obsolete inventory	529			0
Impairment of right-of-use assets	7,434			0
Impairment of fixed assets	30,178			0
Impairment of intangible assets	19,842			0
Loss on disposal of long-lived assets	(33)			1,097
Non-cash lease expense	184			230
Stock compensation expense	462			456
Deferred income tax provision	(133)			17,860
Reduction in tax benefit related to share-based awards	0			24
Changes in current assets and liabilities:
Accounts receivable, net	1,675			(420)
Inventories, net	4,793			(7,661)
Income taxes receivable	(6,212)			(247)
Other current assets	6,926			(18,199)
Accounts payable	(7,666)			(1,306)
Accrued liabilities	(17,522)			(8,157)
Income taxes payable	226			2,428
Interest payable	0			(8)
Net cash used in operating activities	(20,496)			(25,061)
Cash flows from investing activities:
Capital expenditures	(42)			(461)
Proceeds from sale of business	0			169,722
Proceeds from sale of assets	34			132
Abandoned/(purchase) of patents and other intangible assets	49			(103)
Net cash (used in) provided by investing activities	41			169,290
Cash flows from financing activities:
Borrowings on revolving credit facility	0			42,984
Repayments on revolving credit facility	0			(92,715)
Purchase of treasury stock related to share-based awards	(45)			(131)
Proceeds from sale of common stock	349			0
Payments for finance leases	(51)			0
Net cash provided by (used in) financing activities	253			(49,862)
Discontinued operations:
Net cash used in operating activities	0			(337)
Net cash provided by investing activities	0			337
Net cash flows provided by discontinued operations	0			0
Effect of changes in exchange rates on cash and cash equivalents	(109)			2
Net (decrease) increase in cash and cash equivalents and restricted cash	(20,311)			94,369
Cash and cash equivalents at the beginning of period	100,575		96,753	3,044	3,044	3,044	3,044
Restricted cash at the beginning of period	663		660	0	0	0	0
Cash and cash equivalents and restricted cash at beginning of period	101,238		$ 97,413	3,044	$ 3,044	$ 3,044	3,044
Cash and cash equivalents at end of period	80,263	100,575		96,753			100,575
Restricted cash at the end of period	664	663		660			663
Cash and cash equivalents and restricted cash at the end of period	$ 80,927	$ 101,238		$ 97,413			$ 101,238